ICL Group Ltd. — AGM Information 2014

Oct 29, 2014

6-K 1 dp50566_6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2014

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

ISRAEL CHEMICALS LTD.

This report on Form 6-K is being furnished to provide the following information that was filed in Israel by Israel Chemicals Ltd. pursuant to Israeli Securities Law requirements. This report is being furnished and not filed.

1. Immediate report dated October 29, 2014 regarding the ICL Annual and Extraordinary General Meeting

Item 1

ICL Annual and Extraordinary General Meeting

Further to the immediate reports dated October 7, 2014 (reference number 2014-01-172278 and 2014-01-172311), regarding the postponement of the General Meeting, the Company has established December 11, 2014 as the date for its Annual and Extraordinary General Meeting, and has established November 10, 2014, as the record date to determine who is eligible to vote.

Sincerely,

Israel Chemicals Ltd.

Name of the authorized signatory on the report and the name of the authorized electronic signatory: Lisa Haimovitz

Position: Vice President, General Counsel and Corporate Secretary

Date of Signature: October 29, 2014

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Avi Doitchman
Name:	Avi Doitchman
Title:	Executive Vice President, Chief Financial Officer & Strategy

/s/ Lisa Haimovitz
Name:	Lisa Haimovitz
Title:	Vice President, General Counsel and Corporate Secretary

Date: October 29, 2014